INOV Inovalon Holdings Inc. Class A

Walmart Extends Use of the Inovalon ONE® Platform

Walmart Extends Use of the Inovalon ONE® Platform

Retailer Extends Relationship with Inovalon to 2028

BOWIE, Md., June 24, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced an expansion and extension of the long-term engagement with Walmart (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform in its extensive network of pharmacies nationwide as part of its data-driven strategy to improve outcomes and economics for its customers.

Under the agreement, Walmart will extend its engagement into 2028 and will look to expand its use of Inovalon’s cloud-based capabilities through the Inovalon ONE® Platform by extending the use of ScriptMed® Cloud to empower the clinical care management of complex patient populations served by Walmart’s extensive nationwide network of retail pharmacies and to add additional advanced Inovalon ONE® Platform functionality.

The broader Inovalon and Walmart engagement was initiated in 2020 with the implementation of Inovalon’s ScriptMed® Cloud offering, a configuration of the Inovalon ONE® Platform designed to combine analytically driven care protocols with superior quality, operational processes, and cost efficiencies.

“We are committed to a patient-centric approach to dispensing medicine that makes it easy, convenient and fast for our customers to get the medications they need to improve their health,” said Mike Adloo, senior director of Health & Wellness, Walmart.

“Walmart has an impressive track record of innovative approaches to serving their customers, which is providing measurable value to the marketplace,” said Keith Dunleavy, M.D., chief executive officer of Inovalon. “We are honored to work with Walmart and are eager to further contribute to their mission of delivering quality care with the Inovalon ONE® Platform.”

About Inovalon

Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of customers, including all 25 of the top 25 U.S. health plans, all 25 of the top 25 global pharma companies, 24 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 580,000 clinical facilities, 336 million Americans, and 62 billion medical events. For more information, visit .

Contact:

Kim E. Collins

Senior Vice President, Corporate Communications



301-809-4000 x1473

Hulus Alpay

Vice President, Investor Relations



301-809-4000 x1237



EN
24/06/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inovalon Holdings Inc. Class A

 PRESS RELEASE

Equity Consortium Led by Nordic Capital and Including Insight Partners...

Equity Consortium Led by Nordic Capital and Including Insight Partners Completes Acquisition of Inovalon Partnership to Advance Inovalon’s Mission of Empowering Data-Driven Healthcare BOWIE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the completion of its acquisition by an equity consortium led by Nordic Capital, and joined by Insight Partners, as lead co-investor, 22C Capital, and Inovalon founder and chief executive officer Keith Dunleavy, M.D. and certain Class B stockholders o...

 PRESS RELEASE

Pharmacy Leaders and Technology Innovators Convene Virtually November ...

Pharmacy Leaders and Technology Innovators Convene Virtually November 8-9, 2021 Industry Experts Highlight Strategies for Advancing Data Sharing and Improving Pharmaceutical Patient Care at Inovalon’s ScriptMed® Conference BOWIE, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual ScriptMed® Conference will take place virtually from November 8-9, 2021. This prestigious two-day event features the industry’s leading executives and thought leaders discussing the ways in which techno...

 PRESS RELEASE

Inovalon to Host Virtual Client Congress October 18-19, 2021

Inovalon to Host Virtual Client Congress October 18-19, 2021 Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes on Data-Driven Healthcare BOWIE, Md., Oct. 13, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, announced that its annual Client Congress will take place virtually from October 18-19, 2021. Client Congress builds on a decade of bringing together the nation’s most influential voices to address the programs, perspectives, an...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - 2021 08 31

CTSH has built an industry-leading asset-based consulting business over the past 15 years, seeing remarkably stable returns and steady investment in growth, through various economic cycles and potentially impactful regulatory changes. However, the market is expecting both their ability to drive growth and sustain and improve profitability to severely erode going forward, with UAFRS-based (Uniform) ROA falling by half and growth slowing too. While markets are overly pessimistic, management is al...

Valens Research
  • Valens Research

INOV - Embedded Expectations Analysis - 2021 08 30

Inovalon Holdings, Inc. (INOV:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 37.0x Uniform P/E, implying somewhat bullish expectations for the firm. However, although management's concerns about revenue guidance, contract wins, and sales trend disruptions suggest potential short-term headwinds, market expectations are still too pessimistic, and longer-term equity outperformance remains warranted. Specifically, management may lack confidence in ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch